Spencer Pharmaceutical (SPPH)

[sunspotter]

I wonder if any other SPPH victims have been approached by the SEC?

I know the investigation is active, and includes other stocks.

And the Quebecois authority AMF is also still investigating M. Amyot's stock promoting antics.

Any information gratefully received.

[Dan Wilk]

I told the investigator at the SEC that she needs to get ahold of you because you have a wealth of information

[sunspotter]

"I know they are investigating spph hopefully they put them in jail"

Excellent. And I know they're looking way beyond SPPH to other Amyot-sponsored scams. AMF are also cooperating with SEC in aspects of the investigation.

[Dan Wilk]

SEC called me Wednesday afternoon and took a statement from me I talked to them for about 2.5 hrs I know they are investigating spph hopefully they put them in jail

[WarrenPuffett]

lol :)

[sully1215]

WOW a fifty cent order...the volume is pouring in LOL

[sunspotter]

"Because one is born every minute!"

So it would appear. While the SPPH fraud may be in abeyance for the time being, I could name another half dozen identical scams run by the same crew that are currently active.

It's a shame SEC lack the will to do anything about most of these SPPH-type scams until it's too late.

[sully1215]

Because one is born every minute!

[sunspotter]

Hail First Pharma: coming soon!

Well, perhaps not now. Like the Spencer Pharmaceutical website, it has been discontinued, having served its purpose of garnering the email addresses of the naive and gullible.

A mailing list that will be solid gold for Jean François and the boys as they look for new marks for their criminal conspiracies.

http://www.hailfirstpharma.com/

PS, Maxie baby, Ian, J-F - stiil waiting for that subpoena! It's been over a year now, I'm beginning to think you were just kidding. You japesters, you! Govern myself accordingly indeed - great sense of humor, guys!

[sunspotter]

Jean François Amyot has given up the ghost and let the Spencer Pharmaceutical site lapse:

"Our domain monitor detected registration changes in 1 of your monitored domains:

DOMAIN TYPE OF CHANGE OLD VALUE NEW VALUE
SPENCERPHARMACEUTICAL.COM (DomainTools) STATUS REDEMPTION PERIOD PENDING DELETE"


Now you get a typical generic site:

http://www.spencerpharmaceutical.com/

It will be interesting to see what happens with SPPH's "supporters" when the AMF release all the incriminating files found when they seized IAB/Hilbroy's computers. Only another month or so.

[jjstyle]

I cannot tell you my source, so I can be bluffing....
but if I'm right remember me as a good reference :)
There is alot of work to do, because of what happen with Amyot, but there is a legitimate compagnie and the household as started.

[Zorch305]

have you been in communication with Max? Seems they need to update shareholders....

[jjstyle]

I don't expect any major news very soon that could explain this UP, but I think the next PR could be a major one, like a sale of a patent...

[Zorch305]

I'll continue to watch this...just noticed the share price bump and got me interested again....

[jjstyle]

dont give up just yet on this one...
I know for sure that M. Arella is still working to put it back on track

[Zorch305]

what's up here? 250%

[Zorch305]

email from richard

Chris,

We are working on putting the company back on track,

Spencer as you well know is a public company and we are not at liberty to make any statements. The company will issue press releases when appropriate,

All the best for 2012,


Kind regards


Rick

[sunspotter]

Richard T Groome.

[Zorch305]

who's his old bud?

[sunspotter]

"I emailed Notre Dame Capital to see if they are still financial Advisors to Spencer apparently they are."

Given that NDC is run by an old bud of Jean François Amyot who has cooperated with him on some of his other penny stock scams (like SBK), that doesn't particularly surprise me.

[Zorch305]

I emailed Notre Dame Capital to see if they are still financial Advisors to Spencer apparently they are.

[sunspotter]

"Hail was just an Arab pipe dream..."

No, Hail First Pharma is a Canadian company registered, owned and fully controlled by Jean François Amyot, and registered on the XETRA exchange as a part of his scheme to defraud the investing public through the Spencer Pharmaceutical (SPPH) scam:

https://www.ic.gc.ca/app/scr/cc/CorporationsCanada/fdrlCrpDtls.html?corpId=7757557&V_TOKEN=1325512097236&crpNm=hailfirst

https://www.ic.gc.ca/app/scr/cc/CorporationsCanada/fdrlCrpDtls.html?corpId=4413296&V_TOKEN=1325512150501&crpNm=hailfirst


There was never any real Arab interest in SPPH, or Hail First Pharma. (Or in Amyot and Morrice's EGOC shell, for that matter.)

[Zorch305]

I wasn't paying close attention to it...I did know it never looked like it traded....they have to have an actual company in order to be listed they never acquired any business in order to meet compliance of a listing Hail was just an Arab pipe dream...

[sunspotter]

"Noticed Hail First Pharma stopped trading on frankfurt on 12/30/2011."

Actually Hail First Pharma never even started trading. After it was initially registered it was suspended (twice).

On 12/31 it was deleted from XETRA:

http://www.boerse-frankfurt.de/EN/index.aspx?pageID=91&NewsboardID=24613

The SEC are now breathing heavily down Amyot's neck, as are their collaborators, the AMF. I thought originally Jean François Amyot would get away with this one, but now I'm not so sure.

I think there are one or two weak links in the chain of command who've been unnerved by the data discovered on the confiscated IAB/Hilbroy computers.

The whole house of cards is looking a bit wobbly right now, and there's more than "mere" penny stock fraud involved.

[Zorch305]

Noticed Hail First Pharma stopped trading on frankfurt on 12/30/2011.

[sunspotter]

"Our domain monitor detected registration changes in 1 of your monitored domains:

DOMAIN TYPE OF CHANGE

OLD VALUE: SPENCERPHARMACEUTICAL.COM (DomainTools) STATUS CLIENTDELETEPROHIBITED / CLIENTRENEWPROHIBITED / CLIENTTRANSFERPROHIBITED / CLIENTUPDATEPROHIBITED

NEW VALUE: REDEMPTIONPERIOD"

Looks like the beginning of the final official end of this sorry scam.

"REDEMPTIONPERIOD: The registry sets this status when a registrar requests that the domain name be deleted from the registry and the domain has been registered for more than 5 calendar days (if the delete request is received within 5 days of initial domain registration it will instead be deleted immediately). The domain will not be included in the zone. The domain can not be modified or purged; it can only be restored. Any other registrar requests to modify or otherwise update the domain will be rejected. The domain will be held in this status for a maximum of 30 calendar days."

http://whois.domaintools.com/domain-help/status-codes.php

[sunspotter]

"This all done with? Shareprice is really in toilet..."

I thought everybody knew Spencer Pharma was a con job from the minute they started issuing PRs about fictional approvals and equally fictional research projects.

It's what Jean François Amyot does best, after all.

Sadly for him, but happily for the probity of the markets, Monsieur Amyot et ses copains are currently under active investigation by both Canadian securities authorities and SEC, and the seizure of some of his computers with sensitive information about other IAB/Hilbroy sponsored scams has rather cramped his style.

So it's too risky for the boys to run wash trades on SPPH at the moment, hence the recent (lack of) action. And while he's trying to run some other scams from the stable, anything too extravagant will get picked up.

After all, there's a lot of eyes watching the Amyot empire just now, and not all of those eyes belong to the official regulators such as AMF and SEC.

[Zorch305]

This all done with? Shareprice is really in toilet...

[Isthisbull]

i guess they also shut down spencer's website because its not available anywhere

[Lexit]

Would they have met ICCG's CODE OF ETHICS or MINIMUM requirements ????

ROTFL !!!!

for Principal Executive Officer and Senior Financial Officers


SARBANES-OXLEY UPDATE


Effective for annual reports for fiscal years ending after July 15, 2003, each public company will be required to disclose whether or not it has adopted a code of ethics (the “Code of Ethics”) for its principal executive officer, principal financial officer, principal accounting officer or controller, and persons performing similar functions, and will be required to make a copy of its Code of Ethics publicly available to investors.1 Public companies will also be required to publicly disclose any amendments to the key portions of its Code of Ethics, as well as any waivers thereto.




What is required to be disclosed?
New Item 406 of Regulation S-K and related implementing regulations2 will now require each public company to disclose in its annual report the following:

whether the company has adopted a written Code of Ethics that applies to the company's principal executive officer,3 principal financial officer, principal accounting officer or controller and persons performing similar functions (and to make the Code of Ethics publicly available).
If the public company has not adopted a Code of Ethics, an explanation of why it has not done so.
The new rules do not mandate that a public company adopt a Code of Ethics. However, most companies will choose to implement a Code of Ethics because their failure to do so would have to be publicly disclosed. Moreover, the adoption of a Code of Ethics should be taken seriously in light of the continuing focus upon corporate ethics. Public companies that do not already have a compliant Code of Ethics should immediately consider preparing a Code of Ethics that fulfills the requirements of Item 406.

A copy of the Code of Ethics must also be made publicly available through one of three methods:

First, the Code of Ethics may be filed as an exhibit to the company's annual report.
Second, it may be made publicly available on the company's website, if the company provides the appropriate website address and indicates in its annual report its intention to post the Code of Ethics on its website.
Third, public companies may undertake in their annual report to furnish a copy of the Code of Ethics to any person without charge upon request.




What should be contained in the Code of Ethics?
Under the new rules, the term “Code of Ethics” is defined as written standards reasonably designed to deter wrongdoing and to promote:

honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;
full, fair, accurate, timely, and understandable disclosure in SEC reports and documents and other public communications;
compliance with applicable governmental laws, rules and regulations;
prompt internal reporting of violations of the Code of Ethics to the appropriate person(s) identified in the Code of Ethics; and
Accountability for adherence to the Code of Ethics.
Despite public comments requesting that the SEC require the Code of Ethics to cover additional issues, the SEC elected to provide the general set of requirements listed above. However, in its comments accompanying the release of the new rule, the SEC strongly encouraged public companies to adopt codes that are broader and more comprehensive than necessary to meet the new disclosure requirements. In addition, the SEC clarified that the Code of Ethics may be part of a broader code that addresses additional issues and applies to additional persons, such as other executive officers and directors of the company.




Are there any additional disclosure requirements concerning the Code of Ethics?
The new rules also require public disclosure within five business days if either of the following occurs:

any amendment to a provision of the Code of Ethics that applies to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, and that relates to any of the key elements of the Code of Ethics described above; or
a waiver or implicit waiver of any key elements of the Code of Ethics.
These disclosures may be made on Form 8-K or via the company's website by posting such information within five business days. In the case of website disclosure, the company has to have disclosed its website address, as well as its intention to disclose these events on its website, in its most recent annual report.




How does the new SEC requirement compare to the NYSE corporate governance rule proposal concerning codes of business conduct and ethics?
On August 16, 2002, the New York Stock Exchange (“NYSE”) submitted a proposal to the SEC that would require NYSE-listed companies to have a code of business conduct and ethics for directors, officers and employees. As originally proposed, the code of business conduct and ethics would be required to address the following topics:


conflicts of interest;
corporate opportunities;
fair dealing;
protection and proper use of company assets;
compliance with laws, rules and regulations (including insider trading laws); and
reporting of any illegal or unethical behavior.
Any waiver of the code for executive officers or directors could be made only by the board of directors, or a committee of the board, and would have to be promptly disclosed to shareholders. While the NYSE proposal may yet undergo revisions before it becomes final, NYSE-listed companies should review codes of ethics with both SEC and NYSE requirements in mind.

ICCG has defined a set of minimum requirements for certification. Fill out our Corporate Governance questionnaire, our audit team will review it and determine if you are eligible for a certification or not based on the minimum requirement sets below:



Commitment to corporate governance

The basic formalities of corporate governance are in place
The company has a written articulated set of policies or corporate governance code addressing the rights and treatment of shareholders, the role of the board, transparency and disclosure.
The company has a written code of ethics approved by the board



Structure and functioning of the board of Directors

The board meets regularly and deliberates independently of executive management
Board members are given sufficient time and information for analysis and deliberation so that they can exercise their duties of oversight and developing company direction and strategy.
The board includes directors who are neither executives of the company and its affiliates, nor a controlling shareholder.



Transparency and Disclosure

Financial Statements are prepared in accordance with an internationally recognized system of accounting and audited by a recognized independent external auditing firm.
The company complies with all disclosures requirements under applicable laws, regulations and listing rules. Investors and financial analysts are treated equally regarding information disclosure.



Treatment of minority shareholders

Minority shareholders are provided with adequate notice and an agenda of all shareholders’ meetings and are permitted to participate and vote at shareholders’ meetings.
All shareholders of the same class are treated equally with respect to voting rights, subscription rights and transfer rights.
Holders of all securities of the same type and class are treated equally with respect to information disclosure.
Shareholders are provided with accurate and timely information regarding the number of shares of all classes held by controlling shareholders and their affiliates.

http://web.archive.org/web/20100620035729/http://www.i2cg.org/cg_code.php?PHPSESSID=b9f78fe2bd07e3101362678a48309a89

[Unbiased]

Sunspotter, any thoughts on the pharmaceutical VPRO?

[PLAYER ONE]

Spencer Pharmaceutical Applies for Corporate Governance Certificate With ICCG
Thursday, October 21, 2010 9:30 AM

Good thing Spencer has it's own brand of corporate governance. Take the money and run. Think they would have gotten their certificate if the group hadn't been shut down:)

[Lexit]

ICCG website run by Amyot SHUT DOWN by AMF

Google Transalation of the AMF Press Release:

Allegations of stock manipulation - File Wanderport Corp. and Neuro-Biotech inc. - New freeze orders, prohibition and closing Web site are delivered
On Friday, December 2, 2011

Montreal - November 21, 2011, at the request of the AMF, the Bureau decision and revision (BDR) issued a decision which has the effect of broadening the scope of a decision in July 2011 a record of alleged stock market manipulation involving companies Wanderport Corp. and Neuro-Biotech inc.

More specifically, following the consent of Jean-Francois Amyot and Hilbroy Advisory inc., The BDR has ordered the blocking of bank accounts and closing websites and www.glucksteinsilverspoon.com www.i2cg.org. The BDR also prohibited Jean-Francois Amyot as well as companies IAB Media Inc. and Hilbroy Advisory any transaction in securities.

Recall that in July 2011, the BDR had made an order prohibiting all trading in such securities Wanderport Corp. and Neuro-Biotech inc. due to allegations of stock manipulation. The decision also preclude companies Wanderport Corp., 65705442 Canada inc. and Hilbroy Advisory Inc., as well as their officers, directors and employees as well as Jean-Francois Amyot, Andrea Cortelazzi and Andrew Barakett to perform operations on the title of Wanderport Corp.

The BDR was also prohibits Neuro-Biotech Inc., its officers, directors and employees as well as Serge and Andrea Cortellazzi Ollu any transaction in securities of Neuro-Biotech Inc., and ordered the company IAB Media Inc.. to close the website "itsallbull.net" which were promoted titles Wanderport Corp.

In its analysis, the BDR be indicated in the presence of a very complex. "We would be here in the presence of stock market manipulation operations initiated by a large number of people, they have tried over the years to promote the titles of some of the respondent companies to boost the value and then sell the shares they own to cash in profits due to price increases caused by their maneuvers, "stated the BDR in the decision in July.

The AMF is the regulatory and financial sector regulation in Quebec.

- 30 -

Information:

Media only:
Sylvain Théberge: 514 940-2176

Information Center:
Québec: 418 525-0337 / Montreal: 514 395-0337 / Rest of World: 1 877 525-0337

www.lautorite.qc.ca

Source:
http://www.lautorite.qc.ca/fr/communiques-2011-conso.html_2011_allegations-de-manipulations-boursieres-dossier-wanderport-corp-et-neuro-biotech-inc-des-nouvelles-ordonnances-de-blocage-d-interdiction-et-de-fermeture-de-site-web-sont-prononcees02-12-2011-09-3.html

BDRVM decision:

http://www.bdrvm.com/documents/decisions/2011-026_AMF_c._Excel%20Gold%20Mining_global.pdf


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69540556

Spencer Pharmaceutical Applies for Corporate Governance Certificate With ICCG

Thursday, October 21, 2010 9:30 AM

Oct. 21, 2010 (Marketwire) --

BOSTON, MA -- (Marketwire) -- 10/21/10 -- Spencer Pharmaceutical Inc. (PINKSHEETS: SPPH) today announced that it has applied for a Level 1 certificate with the International Council for Corporate Governance (ICCG). The certificate application is a 2 step process. First a questionnaire to be filled out by a company executive is completed. This is reviewed by the ICCG Audit Committee. Then the Companies Executives and Board of Directors will review and in conjunction with ICCG adopt a code of ethics prepared with ICCG. If satisfactory, ICCG will then issue a certification with all details published on www.spencerpharmaceutical.com

"As an OTC Pinksheet listed company we have high standards in our reporting and transparency procedures corporately as well as scientifically," stated Dr. Max Arella, President of Spencer Pharmaceutical Inc., furthermore, "we believe it is our corporate duty to continually improve our already high standards of reporting to investors with our ultimate goal being the improved value of our company to our current shareholders and future investors," added Dr. Arella.

About The International council for Corporate Governance:

The International Council for Corporate Governance is an International membership organization that provides publicly traded companies with a practice model for Corporate Governance Disclosure. Their goal is to increase the standard of corporate transparency and corporate governance disclosure to increase investor confidence. For more information please visit: www.i2cg.org

http://www.istockanalyst.com/article/viewiStockNews/articleid/4600785

CAVEAT EMPTOR !!!

[Isthisbull]

Puppet master amyot is controlling not only dr arella but also the head of two universities, the editor of gene therapy, I think he also managed all research in the lab, animal studies, and I believe he decides if people get a phd or not...not a puppet master, he is the puppet master...lol

If spph tech was so general and without any value, why would gene therapy publish the research developed by spph as a breakthrough? Naturally, you should answer this because I have very, very limited knowledge on this science.

Even if it has value, the company can't pay it's partners so they will lose it anyways

[sunspotter]

"therefore if spph has the technology they say they have it should be a no brainer..."

Nonsense.

The technology SPPH claim to have is merely a modified release technology, the likes of which are almost literally ten a penny.

Indeed not only did Merck have its own MR technology, it acquired many others when it bought Schering recently, including Repetabs.

The matrix technology SPPH claims to have in-licensed from UQAM is commonplace.

It might be worth tens of thousands of dollars if it actually exists, and has robust IP behind it.

But as we have determined that all of those associated with this company - Maximilien Arella, Ian Morrice and Robert Albi - not to forget real SPPH puppetmaster Jean François Amyot - are inveterate and incurable liars and con merchants, we would be extremely foolish to take them at their word.

[Isthisbull]

Merck makes estimates on diabetes drug and aims research and marketing towards further developing this market. Turns out one of merck largest research facility is in the backyard of spph. It should be simple for dr arella to get at least a meeting let alone some kind of deal. They have huge budget for research and therefore if spph has the technology they say they have it should be a no brainer...

[Isthisbull]

Perhaps they don't have any money for a press release.

[Isthisbull]

The diabetic market is becoming one of the most important market for the large pharma. The drug delivery developed by spph has good chance if it was licensed to a large pharma who can spend the money for the clinical phases. They could get a fast track but considering it's not a big pharma requesting, it is unlikely it be granted without at least a 200 patient clinical trial. This would cost a minimum of $500,000 but the company does not have funds to pay anyone or anything. Dr arella has gone back to teaching to pay his mortgage and therefore not much is being done to get the financing

Dr arella has great contacts in the middle east and it still remains the best option for the company. I'm not suggesting a deal with hail first pharma since that ship has sailed but other contacts of dr arella.

[antmtl]

Why dont you post your thoughts or findings on SPPH ?

you continue to defend Amyot and IAB media?!? ISNT HE NO LONGER WITH SPENCER? and IAB are shut down arent they?

your prosting on SPPH board, what have you to discuss about the Co.?

[Isthisbull]

Naturally all signed documents are binding, I agree with you and much like Carol and denies, if they participated in press releases and signed documents, well nothing they can say or do. I doubt it to be the reality in the case of iab and therefore who cares. If you know of press releases and or documents signed by Julie or if you have any information that can show that she was working with iab, please share, otherwise the information provided is irrelevant. Like I said, he could have his mother, uncle and grand mother listed in the register, if they never worked there, the good work of the amf should easily identify and clarify this fact don't you think. Unless they are not doing their work!

[Lexit]

The unfortunate fact is that Amyot placed Ms. Forget's name on this public document, and that's the only thing the public has to rely on.

Much like Denyse Raynault who appears on a profusion of incorporation documents and press releases, they are PUBLIC documents.

When you sign on the line that is dotted, all the responsibilities that are connected to that signature are binding.

[Lexit]

Point is that he didn't and the Registry document stands as A PUBLIC FACT.

[Isthisbull]

Still being listed as treasurer n secretary in some registry and even on the Internet somewhere does not make it so. On the other hand if you are active in the business like Dan ryan's wife now that's a different story. If she signed contracts, cheques, authored press releases etc than that makes her a partner. A little different don't you think

[Isthisbull]

I'm sure he could have removed his own name as well. With the kind of money he has, he could have paid someone in his place. Instead, he is there, present and mostly still in business

[Lexit]

Read carefully, I never said they knew each other....

[Lexit]

Fact is, that Amyot didn't update it when he could of and the info is there.

[Isthisbull]

That's a big stretch! Have you found anything authored?

[Isthisbull]

Who cares about the Quebec registry. How do you know the infortion was not filled and never updated by the government. Perhaps there is more to the story. In any case, who cares, even if his mother, uncle and dead grand mother were listed what would it changed. I can add that even if he was not listed and he put someone else in his place that would not have made a difference nor would it make any difference with the cease trade if the amf did their work properly.

[Lexit]

I think Julie Forget should to a Meet and Greet with Denyse Raynault.

My info is that Denyse Raynault can barely speak or write English yet she's the signatory of a significant number of press releases for HRRN.

I can only wonder how Ms. Raynault will bear up to Revenu Quebec, the AMF etc....

I fear the same fate for Ms. Forget is possible.

[Lexit]

ROTFL...you can't just ignore the Quebec Registry.

The information was placed there by Amyot and he ddin't update it, it's Amyot's responsibility to update not the AMF

ROTFL....yup, Julie Forget is still there.


État de renseignements d'une personne morale au registre des entreprises

Numéro de dossier Nom Adresse Statut Date du changement d'état Statut du nom Date initiale Date finale

1166189416 IAB MÉDIA INC. 1400 rue Bégin Montréal (Québec) H4R1X1 Canada Immatriculée 2009-10-28 En vigueur 2009-10-28


Légende par défaut Renseignements en date du 2011-10-28 10:24:51
Informations générales
Identification de l'entreprise
Légende par défaut
Nom de l'entreprise IAB MÉDIA INC.
IAB MÉDIA INC.
Numéro d'entreprise du Québec (NEQ)
Adresse du domicile
Légende par défaut
Adresse 1400 rue Bégin
Montréal (Québec) H4R1X1
Canada

Adresse du domicile élu (adresse de correspondance)
Légende par défaut
Adresse Aucune adresse
Immatriculation
Légende par défaut
Date d'immatriculation
Statut Immatriculée
Immatriculée
Date d'entrée en vigueur du statut d'immatriculation
Date de cessation prévue Aucune date de cessation n'est prévue.
Aucune date de cessation n'est prévue.
Forme juridique
Légende par défaut
Type Compagnie
Compagnie
Date de formation 2009-10-23 00:00:00 Constitution
2009-10-23 00:00:00 Constitution
Lieu de constitution (province, État, pays) CANADA
CANADA
Régime constitutif CANADA : Loi canadienne sur les sociétés par actions, L.R.C. (1985) c. C-44
CANADA : Loi canadienne sur les sociétés par actions, L.R.C. (1985) c. C-44
Régime courant CANADA : Loi canadienne sur les sociétés par actions, L.R.C. (1985) c. C-44
CANADA : Loi canadienne sur les sociétés par actions, L.R.C. (1985) c. C-44
Dates des mises à jour
Légende par défaut
Date de mise à jour de l'état de renseignements
Date de la dernière déclaration de mise à jour annuelle 2010-06-25 00:00:00 2010
2010-06-25 00:00:00 2010
Date de fin de la période de production de la déclaration de mise à jour annuelle de 2011
Date de fin de la période de production de la déclaration de mise à jour annuelle de 2010
Faillite
Légende par défaut L'entreprise n'est pas en faillite.
Entreprises liées
Légende par défaut L'entreprise n'a fait l'objet d'aucune procédure légale la liant à une autre entreprise.
Continuation ou transformation
Légende par défaut L'entreprise n'a fait l'objet d'aucune continuation ou transformation.
Liquidation ou dissolution
Légende par défaut L'entreprise ne fait pas l'objet d'une liquidation ou d'une dissolution.
Activités économiques et nombre de salariés

1er secteur d'activité
Légende par défaut
CAE
Description Autres services de publicité
Autres services de publicité
Précisions (facultatif) PROMOTION SUR SITE WEB
PROMOTION SUR SITE WEB
2e secteur d'activité
Légende par défaut Activité non déclarée


Nombre de salariés
Légende par défaut
Nombre de salariés au Québec

Personnes liées
Actionnaires
Légende par défaut Premier actionnaireLe premier actionnaire est majoritaire.
Nom HILBROY ADVISORY INC.
HILBROY ADVISORY INC.
Adresse 1400, BEGIN SAINT-LAURENT (QUÉBEC) H4R1X1
1400, BEGIN SAINT-LAURENT (QUÉBEC) H4R1X1
Membres du conseil d'administration
Légende par défaut
Nom AMYOT, JEAN-FRANÇOIS
AMYOT, JEAN-FRANÇOIS
Fonction Administrateur
Administrateur
Date de début du mandat
Date de fin du mandat
Adresse 1999, BOULEVARD ALEXIS-NIHON SAINT-LAURENT (QUÉBEC) H4R3C4
1999, BOULEVARD ALEXIS-NIHON SAINT-LAURENT (QUÉBEC) H4R3C4 Légende par défaut
Nom FORGET, JULIE
FORGET, JULIE
Fonction Trésorier
Trésorier Date de début du mandat
Date de fin du mandat
Adresse 1999, BOULEVARD ALEXIS-NIHON SAINT-LAURENT (QUÉBEC) H4R3C4
1999, BOULEVARD ALEXIS-NIHON SAINT-LAURENT (QUÉBEC) H4R3C4 Légende par défaut
Nom FORGET, JULIE
FORGET, JULIE
Fonction Secrétaire
Secrétaire Date de début du mandat
Date de fin du mandat
Adresse 1999, BOULEVARD ALEXIS-NIHON SAINT-LAURENT (QUÉBEC) H4R3C4
1999, BOULEVARD ALEXIS-NIHON SAINT-LAURENT (QUÉBEC) H4R3C4
Personnes non membres du conseil d'administration
Légende par défaut PrésidentIl n'y a pas de président.
Légende par défaut SecrétaireIl n'y a pas de secrétaire.
Légende par défaut Principal dirigeantIl n'y a pas de principal dirigeant.

Fondé de pouvoir
Légende par défaut
Il n'y a pas de fondé de pouvoir.

Administrateurs du bien d'autrui
Légende par défaut
Il n'y a pas d'administrateur du bien d'autrui.

Établissements
Légende par défaut Il n'y a aucun établissement.
Documents
Documents en traitement
Légende par défaut Aucun document n'est actuellement traité par le Registraire des entreprises.
Documents conservés
Type de document Date de traitement

Déclaration de mise à jour courante 2011-07-11 18:01:27
Modification correction / Acte de régularisation 2010-11-01 00:00:00
Déclaration modificative 2010-08-13 00:00:00
Déclaration annuelle 2010 2010-06-25 00:00:00
Déclaration d'immatriculation 2009-10-28 00:00:00

Nom et autres noms utilisés au Québec
Légende par défaut
Date de mise à jour de l'index des noms
Nom
Nom de l'entreprise Version du nom dans une autre langue Date d'entrée en vigueur Date de fin d'utilisation Statut

IAB MÉDIA INC. IAB MEDIA INC. 2009-10-28 00:00:00 En vigueur

Autres noms utilisés au Québec
Autre nom Version du nom dans une autre langue Date d'entrée en vigueur Date de fin d'utilisation Situation

https://www.registreentreprises.gouv.qc.ca/RQAnonymeGR/GR/GR03/GR03A2_19A_PIU_RechEnt_PC/PageResultat.aspx?T1.JetonStatic=5cd1c8cb-e514-435b-a1f2-ca2611966622&T1.CodeService=S00436#_ctl0_CPH_K1ZoneContenu1_Cadr_IdSectionResultat_IdSectionResultat_K1DetailsRecherche_Ancre